The discussion highlights the inadequate methods used to assess the safety of endocrine-disrupting chemicals, often relying on simplistic measures like organ weight. There's a stark contrast between the rigorous testing of pharmaceuticals and the lax regulation surrounding food additives, leading to potential health risks. The conversation also touches on the alarming reality of medical devices being approved based on similarities to previous products, raising concerns about long-term safety.
